Abstract: This application provides an interaction method in a virtual scene performed by an electronic device. The method includes: displaying a plurality of interaction objects and at least one interaction control in a virtual scene; controlling, in response to a press operation for a first interaction control, the first interaction control to be in a pressed state; controlling, in response to a selection operation for a first interaction object that is triggered based on the first interaction control in the pressed state, the first interaction object to be in a selected state; and performing, in response to a release operation for the press operation, an interaction operation associated with the first interaction control for the first interaction object.

Abstract: The present invention relates to a cathepsin K inhibitor having the structure as shown in formula (0) and/or formula (II), wherein cyanopyrimidine or a keto group as an electrophilic group is a key group to exert a good inhibitory effect on cathepsin K. Further provided are a preparation method therefor and use thereof. The provided cathepsin K inhibitor has a relatively high inhibitory effect and selectivity, and is expected to be used for treating diseases including thyroid diseases, cardiovascular diseases, bone diseases and gum diseases.

Abstract: The present application discloses an air conditioner control method. The method includes obtaining a position of a user; detecting that the position of the user meets a preset condition, and obtaining a target operating parameter of an air conditioner, the preset condition being determined according to a preset running time span, and the preset running time span being determined according to a current environmental parameter and a target environmental parameter, and the current environmental parameter comprising at least one of a current indoor temperature, a current indoor humidity, a current air cleanliness and a current air freshness; and controlling the air conditioner at a target position to operate with the target operating parameter. The present application also discloses an air conditioner, a server and a computer readable storage medium.

Abstract: Disclosed are a compound of formula I or a pharmaceutically acceptable salt thereof, and use thereof in regulating and controlling an EGFR tyrosine kinase activity or preventing and treating an EGFR-related disease. The EGFR inhibitor of formula I has an inhibitory activity on EGFR D770-N771 ins NPG and NPG/T790M kinases, and an inhibitory effect on an EGFR-Del19/T790M/C797S kinase and cell proliferation of a KC-0122:Ba/F3EGFR-L858R/T790M/C797S three-mutation cell line and a KC-0116:Ba/F3EGFR-Del19/T790M/C797S three-mutation cell line.

Abstract: Some embodiments of the invention provide a method of performing end-user monitoring. At a health monitor that executes on a first host computer along with a client machine and a load balancer, to monitor health of a set of two or more servers that are candidate servers for processing packets from the client machine, the method exchanges health monitoring messages with each server in the set of servers to assess health of the servers in the set. At the health monitor, the method provides health data expressing health of the servers to the load balancer to use in determining how to distribute packets from the client machine between the servers in the set of servers.

Abstract: The invention proposes a high-pressure environment biological enrichment and spray-type solid isolation and cultivation device, including a spray-type isolation and cultivation solid unit, and a biological enrichment unit. In the case of constructing a high-pressure, low-temperature environment consistent with the marine environment, the biological enrichment unit is used to realize enrichment and multi-stage purification process of marine microorganisms, obtain a biological enrichment fluid and inject the biological enrichment fluid into the spray-type isolation and cultivation solid unit; and the spray-type isolation and cultivation solid unit is use to convert the biological enrichment fluid into a state of microbeads, so that the biological enrichment fluid can be isolated and cultivated in a dispersed state.

Abstract: Some embodiments provide a method for performing data traffic monitoring. The method processes a packet through a packet processing pipeline that includes multiple stages. At a filtering stage, the method tags the packet with a set of monitoring actions for subsequent stages to perform on the packet based on a determination that the packet matches a particular filter. For each stage of a set of packet processing stages subsequent to the filtering stage, the method (i) executes any monitoring actions specified for the stage to perform on the packet and (ii) sends the packet to a next stage in the packet processing pipeline.

Abstract: The present invention belongs to the field of medical technology and specifically relates to an active ingredient group for treating constipation. An active ingredient group for treating constipation, characterized in that the active ingredient group includes rhein, hesperetin, albiflorin, and magnolol. The key target combination of constipation includes RXRA, CYP1A1, CYP1A2 and PLA2G4. The active ingredient group for treating constipation provided in this application can effectively prevent and treat constipation by regulating bile acid secretion, steroid hormone biosynthesis, glycerophospholipid metabolism, and linoleic acid metabolism by establishing strong combination between the active ingredient group and the key target combination of constipation. This application also discloses the biomarkers for the diagnosis and treatment of constipation.

Abstract: The present invention belongs to the field of medical technology and specifically relates to an active ingredient group for treating UC. An active ingredient group for treating UC, characterized in that it uses an active ingredient group to act on key target combination of UC, and prevents and treats UC by regulating tryptophan metabolism, glycerolphospholipid metabolism, and linoleic acid metabolism. The active ingredient group for treating UC provided in this application can effectively prevent and treat UC by regulating tryptophan metabolism, glycerolphospholipid metabolism and linoleic acid metabolism by establishing strong combination between the active ingredient group and the key target combination of UC. This application also discloses the biomarkers for the diagnosis and treatment of UC.

Abstract: Some embodiments of the invention provide a method of migrating a virtual machine (VM) from a first host computer to a second host computer, the first host computer having a first PNIC, the second host computer having a second PNIC, the first and second PNICs for performing at least one of network forwarding operations and middlebox service operations for the VM. At an RDMA client executing on a set of one or more processors of the second PNIC, the method receives a notification from the second host computer indicating a data migration that is performed to migrate the particular VM from the first host computer to the second host computer has started. Based on the notification, at the RDMA client, the method directs an RDMA server executing on the first PNIC to provide networking state data associated with at least one of network forwarding operations and middlebox service operations that the first PNIC performs for the VM.

Abstract: A traditional Chinese medicine composition for treating neuritis. The traditional Chinese medicine composition is prepared mainly from Notopterygii Rhizoma et Radix, Angelicae Pubescentis Radix, Poria, Saposhnikoviae Radix, Schizonepetae Herba, Chuanxiong Rhizoma, Platycodonis Radix, Bupleuri Radix, Peucedani Radix, Aurantii Fructus, and Glycyrrhizae Radix et Rhizoma. The traditional Chinese medicine composition can significantly relieve facial paralysis, movement disorders, and other related symptoms of facial neuritis in a rat, remarkably improve expression of VEGFb, VEGFR1, and VEGFR2 proteins in postoperative side facial nerves of the rat, and promote recovery and regeneration of damaged rear axons.

Abstract: Some embodiments of the invention provide a method of migrating a VM from a first host computer to a second host computer, the first host computer having a first PNIC that performs at least one of network forwarding operations and middlebox service operations for the VM. At an RDMA client executing on a set of one or more processors of the first host computer, the method directs an RDMA server executing on the first PNIC to provide networking state data associated with at least one of network forwarding operations and middlebox service operations that the first PNIC performs for the VM. The provided networking state data resides in a memory of the first PNIC that is accessible to the RDMA server. At the RDMA client, the method provides the obtained networking state data to the second host computer as part of a data migration that is performed to migrate the VM from the first host computer to the second host computer.

Abstract: An example method of beacon probing in a computing system includes: sending, by cross-host beacon probing (CHBP) software executing in a first host of the computing system, a first beacon probe from a first network interface controller (NIC) of the first host to NICs on a same layer 2 domain as the first NIC, the NICs including a second NIC of the first host and cross-host NICs of at least one host other than the first host; receiving, at the CHBP software through the first NIC, acknowledgements (ACKs) to the first beacon probe from the cross-host NICs; and determining, in response to the first beacon probe, connectivity statuses of the first NIC and the second NIC by the CHBP software based on the ACKs and on whether the second NIC receives the first beacon probe.

Abstract: A forecast for compatible advertisement opportunities, compatible with a class of advertisements, that will be available over a future time period is generated. For a content item associated with one or more advertisement opportunities, one or more compatible advertisement opportunities of the one or more advertisement opportunities are determined based on characteristics of the class of advertisements. Expected output of the content item over the future time period may be determined from historical data of output of other content items similar to the content item, and may be adjusted based on additional information, such as actual output of the content item. The forecast may be generated from the compatible advertisement opportunities associated with the content item and the expected output of the content item.

Abstract: Disclosed is a traditional Chinese medicinal composition for treating neurogenic pulmonary edema. The traditional Chinese medicinal composition is mainly prepared from Notopterygium root, angelicae pubescentis radix, poria cocos, radix saposhnikoviae, herba schizonepetae, rhizoma chuanxiong, platycodonis radix, radix bupleuri, common hogfennel root, fructus aurantii, and licorice root. The traditional Chinese medicinal composition can improve a lung index and lung wet weight/dry weight of a rat with neurogenic pulmonary edema, and has a therapeutic effect on the neurogenic pulmonary edema.

Abstract: An example method of distributed load balancing in a virtualized computing system includes: configuring, at a logical load balancer, a traffic detector to detect traffic to a virtual internet protocol address (VIP) of an application having a plurality of instances; detecting, at the traffic detector, a first request to the VIP from a client executing in a virtual machine (VM) supported by a hypervisor executing on a first host; sending, by a configuration distributor of the logical load balancer in response to the detecting, a load balancer configuration to a configuration receiver of a local load balancer executing in the hypervisor for configuring the local load balancer to perform load balancing for the VIP at the hypervisor using the load balancer configuration.

Abstract: A pharmaceutical composition for preventing or treating Alzheimer's disease and use thereof are disclosed and belong to the technical field of medicines. The pharmaceutical composition includes (Z)-3-(N-(3-bromo-4-fluorophenyl)-N?-hydroxyformamido)-4-(2-guanidinoethyl)amino)-1,2, 5-oxadiazole and anhydroicaritin. A pharmacodynamic experiment proves that the pharmaceutical composition achieves a synergistic therapeutic effect on treating Alzheimer's disease.

Abstract: Example methods and systems for validation-based service request handling are described. In one example, a computer system may obtain, from a management entity, configuration information specifying a unicast service address associated with a service node capable of providing a network service. In response to detecting a service request from the virtualized computing instance, the computer system may generate a modified service request that (a) is destined for the unicast service address and (b) includes a validation identifier (ID) associated with the virtualized computing instance. The modified service request may be forwarded towards the service node to cause the service node to perform validation based on the validation ID to determine whether to provide the network service. In response to detecting a service response from the service node, the service response, or a modified service response, may be forwarded towards the virtualized computing instance.

Abstract: The present invention provides a device for separating a single colony in a deep-sea in-situ environment. The device includes a separation operation incubator, a liquid injection unit, a sampling unit, and a sampling probe device. The present invention further provides a method for separating a single colony in a deep-sea in-situ environment. The method includes: under the condition of maintaining the pressure and temperature in the separation operation incubator consistent with those of a culture environment of deep-sea microorganisms, injecting a microbial bacterial liquid into the separation operation incubator through the liquid injection unit; carrying out dipping and streaking operations by the sampling probe device; then, carrying out separation and culture; and at last, selecting a single colony by the sampling unit to realize separation of a single colony.

Abstract: The present invention provides a membrane bioreactor for deep-sea cold seeps. The bioreactor is used for simulating a biomembrane growth process during anaerobic oxidation of methane (AOM) in the cold seeps and monitoring changes of environmental conditions thereof. The present invention further provides an online environmental parameter measurement system for a membrane biological reaction in the deep-sea cold seeps. The system includes a fluid supply unit used for generating saturated methane fluid and injecting the saturated methane fluid into the membrane bioreactor for the deep-sea cold seeps at a microflow, and a pressurization system used for ensuring stability and consistency of internal environmental pressure of the system in a simulation process.